stars 1 stars 2 stars 3

Hatchtech Pty Ltd is an innovative biotechnology company developing novel solutions for everyday health problems based in Melbourne, Australia. Its lead development product, Xeglyze™, is a single dose, single treatment, topical prescription product for the control of head lice and was approved by the FDA in July 2020.

Hatchtech Pty Ltd Questions

The Hatchtech Pty Ltd annual revenue was $7 million in 2026.

Hatchtech Pty Ltd is based in Camberwell, Victoria.

The NAICS codes for Hatchtech Pty Ltd are [32541, 3254, 32, 325].

The SIC codes for Hatchtech Pty Ltd are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users